Natera price target raised to $160 from $135 at JPMorgan

JPMorgan raised the firm’s price target on Natera (NTRA) to $160 from $135 and keeps an Overweight rating on the shares. The company reported another very strong quarter, the analyst tells investors in a research note. The firm says Natera “continues to fire on all cylinders” from a volume, selling price, margin and cash burn perspective with room for further improvement heading into 2025. Following the quarter, it continues to believe Natera is of the highest quality companies in the diagnostics space.